Annual Gross Profit
$73.40 M
+$15.70 M+27.21%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual gross profit is $73.40 million, with the most recent change of +$15.70 million (+27.21%) on December 31, 2023.
- During the last 3 years, YMAB annual gross profit has risen by +$54.86 million (+295.77%).
- YMAB annual gross profit is now at all-time high.
Performance
YMAB Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$16.21 M
-$3.57 M-18.05%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly gross profit is $16.21 million, with the most recent change of -$3.57 million (-18.05%) on September 30, 2024.
- Over the past year, YMAB quarterly gross profit has dropped by -$5.11 million (-23.97%).
- YMAB quarterly gross profit is now -44.90% below its all-time high of $29.43 million, reached on December 31, 2022.
Performance
YMAB Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$75.11 M
-$1.60 M-2.08%
September 30, 2024
Summary
- As of February 7, 2025, YMAB TTM gross profit is $75.11 million, with the most recent change of -$1.60 million (-2.08%) on September 30, 2024.
- Over the past year, YMAB TTM gross profit has increased by +$1.70 million (+2.32%).
- YMAB TTM gross profit is now -7.85% below its all-time high of $81.51 million, reached on September 30, 2023.
Performance
YMAB TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
YMAB Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | -24.0% | +2.3% |
| 3 y3 years | +295.8% | -44.9% | +30.2% |
| 5 y5 years | - | -44.9% | +30.2% |
YMAB Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +126.7% | -44.9% | +99.3% | -7.8% | +131.9% |
| 5 y | 5-year | at high | -100.0% | -44.9% | -100.0% | -7.8% | -100.0% |
| alltime | all time | at high | -100.0% | -44.9% | -100.0% | -7.8% | -100.0% |
Y-mAbs Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.21 M(-18.0%) | $75.11 M(-2.1%) |
| Jun 2024 | - | $19.78 M(+11.2%) | $76.70 M(+5.0%) |
| Mar 2024 | - | $17.78 M(-16.6%) | $73.02 M(-0.5%) |
| Dec 2023 | $73.40 M(+27.2%) | $21.32 M(+19.7%) | $73.40 M(-9.9%) |
| Sep 2023 | - | $17.81 M(+10.6%) | $81.51 M(+10.5%) |
| Jun 2023 | - | $16.10 M(-11.4%) | $73.76 M(+9.7%) |
| Mar 2023 | - | $18.17 M(-38.3%) | $67.21 M(+16.5%) |
| Dec 2022 | $57.70 M | $29.43 M(+192.5%) | $57.70 M(+58.5%) |
| Sep 2022 | - | $10.06 M(+5.3%) | $36.41 M(+4.7%) |
| Jun 2022 | - | $9.56 M(+10.4%) | $34.76 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $8.65 M(+6.4%) | $35.75 M(+10.4%) |
| Dec 2021 | $32.38 M(+74.6%) | $8.14 M(-3.3%) | $32.38 M(-24.3%) |
| Sep 2021 | - | $8.41 M(-20.2%) | $42.79 M(+24.5%) |
| Jun 2021 | - | $10.54 M(+99.3%) | $34.38 M(+44.2%) |
| Mar 2021 | - | $5.29 M(-71.5%) | $23.84 M(+28.5%) |
| Dec 2020 | $18.55 M(>+9900.0%) | $18.55 M(>+9900.0%) | $18.55 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Y-mAbs Therapeutics annual gross profit?
- What is the all time high annual gross profit for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual gross profit year-on-year change?
- What is Y-mAbs Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly gross profit year-on-year change?
- What is Y-mAbs Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics TTM gross profit year-on-year change?
What is Y-mAbs Therapeutics annual gross profit?
The current annual gross profit of YMAB is $73.40 M
What is the all time high annual gross profit for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual gross profit is $73.40 M
What is Y-mAbs Therapeutics annual gross profit year-on-year change?
Over the past year, YMAB annual gross profit has changed by +$15.70 M (+27.21%)
What is Y-mAbs Therapeutics quarterly gross profit?
The current quarterly gross profit of YMAB is $16.21 M
What is the all time high quarterly gross profit for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly gross profit is $29.43 M
What is Y-mAbs Therapeutics quarterly gross profit year-on-year change?
Over the past year, YMAB quarterly gross profit has changed by -$5.11 M (-23.97%)
What is Y-mAbs Therapeutics TTM gross profit?
The current TTM gross profit of YMAB is $75.11 M
What is the all time high TTM gross profit for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high TTM gross profit is $81.51 M
What is Y-mAbs Therapeutics TTM gross profit year-on-year change?
Over the past year, YMAB TTM gross profit has changed by +$1.70 M (+2.32%)